We use these cookies to anonymously measure the performance of our website through the Google Analytics platform.
We use these cookies to deliver a seamless user experience for those customers and users that have created an account with us for receiving email communications.
We use the LinkedIn Ads cookie to track the success of LinkedIn advertising campaigns. This cookie is an anlytics tool that allows us to measure the effectiveness of advertising.
Imagine what you could do if working with poorly soluble compounds was not an insurmountable issue.
Our SILSOL? silica active ingredient delivery technology combines Grace's extensive expertise in mesoporous silica gel, novel application methods, and patent pending technologies to accelerate the screening and development of solubility enhancing solid dispersions, with the added benefit of doing so with compendial, scalable, and available silicas.
Compared to other bioavailability enhancing techniques such as particle size reduction, complexation, lipid-based systems, and polymer-based solid dispersions, our SILSOL? silica technology introduces techniques that
are easier to screen and work in combination with existing technologies to improve usage and stability, thereby reducing the time needed to scale up.
Grace's SILSOL? silica active ingredient delivery technology is used with solvent impregnation to create amorphous solid dispersions.
Due to our vast expertise in particle design, Grace can modify the pore size and surface characteristics of silica to accommodate various API molecules. The net result is enhanced bioavailability with improved stability.
SILSOL? Silica-based Drug Delivery Technology